ImmunityBio, Inc. Quarterly Current Ratio in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
ImmunityBio, Inc. quarterly Current Ratio history and growth rate from Q2 2016 to Q3 2024.
  • ImmunityBio, Inc. Current Ratio for the quarter ending September 30, 2024 was 381 %, a 1158% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 381 +351 +1158% Sep 30, 2024
Q2 2024 358 +332 +1252% Jun 30, 2024
Q1 2024 94.6 +60.7 +179% Mar 31, 2024
Q4 2023 52 +5.97 +13% Dec 31, 2023
Q3 2023 30.3 -37 -55% Sep 30, 2023
Q2 2023 26.5 -37 -58.2% Jun 30, 2023
Q1 2023 33.9 -51 -60.1% Mar 31, 2023
Q4 2022 46 -63.1 -57.8% Dec 31, 2022
Q3 2022 67.2 -78.5 -53.9% Sep 30, 2022
Q2 2022 63.5 -111 -63.5% Jun 30, 2022
Q1 2022 84.8 -144 -62.9% Mar 31, 2022
Q4 2021 109 -198 -64.5% Dec 31, 2021
Q3 2021 146 -241 -62.3% Sep 30, 2021
Q2 2021 174 -219 -55.7% Jun 30, 2021
Q1 2021 229 -152 -40% Mar 31, 2021
Q4 2020 307 -91.5 -22.9% Dec 31, 2020
Q3 2020 387 -64.6 -14.3% Sep 30, 2020
Q2 2020 393 -6.07 -1.52% Jun 30, 2020
Q1 2020 381 -10.1 -2.59% Mar 31, 2020
Q4 2019 399 -39.4 -8.99% Dec 31, 2019
Q3 2019 452 -65.6 -12.7% Sep 30, 2019
Q2 2019 399 -192 -32.5% Jun 30, 2019
Q1 2019 391 -174 -30.8% Mar 31, 2019
Q4 2018 438 -224 -33.9% Dec 31, 2018
Q3 2018 517 -284 -35.4% Sep 30, 2018
Q2 2018 590 -489 -45.3% Jun 30, 2018
Q1 2018 565 -1.21K -68.1% Mar 31, 2018
Q4 2017 663 -1.46K -68.8% Dec 31, 2017
Q3 2017 801 -1.99K -71.3% Sep 30, 2017
Q2 2017 1.08K -2.5K -69.9% Jun 30, 2017
Q1 2017 1.77K Mar 31, 2017
Q4 2016 2.12K Dec 31, 2016
Q3 2016 2.79K Sep 30, 2016
Q2 2016 3.58K Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.